Abstract:Background Emergence and predominance of hepatitis B virus (HBV) variants carrying S gene mutations frequently occur in HBV-infected individuals. Here, coexistent serum anti-HBsAg antibody (HBsAb) and HBV surface antigen (HBsAg) were detected in a chronic HBV patient. The patient's HBsAg proteins possessed amino acid substitutions sK122R and sV96A. We reported this case and conducted relevant studies to investigate differences in expression levels and antibody neutralization of HBsAg proteins bearing sK122R and sV96A amino acid substitutions to explore causes of antigen-antibody coexistence in a chronic hepatitis B patient. Study design We first sequenced the S gene from HBV present within the patient's serum. Based on the S gene sequence, we cloned wild-type and mutated S gene sequences via site-directed mutagenesis to construct expression plasmids pJW4303-WT (wild-type), pJW4303-sV96A, pJW4303-sK122R, and pJW4303-sV96A-sK122R. Plasmids were transfected into HEK 293 T cells then culture supernatants and cells were collected. Collected cells and supernatants were next subjected to a series of quantitative and functional tests to assess expression and neutralization characteristics of wild-type and mutant HBsAg proteins. Results Based on quantification of HBsAg expression in cells transfected with the four plasmids, HBsAg-sK122R-sV96A was more intracellularly retained and less secreted than HBsAg-sV96A single-mutant protein and WT. Neutralization ability of serum from chronic HBV patient against culture supernatants containing recombinant HBsAg proteins were ranked from highest to lowest as HBsAg-sV96A, HBsAg-sV96A-sK122R, and HBsAg-sK122R. However, no significant differences of neutralization efficiency by high-potency antibodies from HBV-vaccinees against these three mutant proteins were observed. Conclusions The levels of HBsAg proteins with amino acid substitutions sV96A-sK122R were greatly reduced in culture supernatants but were apparently increased in the intracellular fraction. This may account for the higher levels of HBV replication in patients. HBsAg neutralization by HBsAb in this patient may have been compromised by the HBsAg sK122R amino acid substitution, suggesting that antibodies produced by the patient had lost their HBV-neutralizing effect.

Mutations in Surface and Polymerase Gene of Chronic Hepatitis B Patients with Coexisting Hbsag and Anti-Hbs

Mutations in hepatitis B virus DNA from patients with coexisting HBsAg and anti-HBs.

Mutations in the S Gene and in the Overlapping Reverse Transcriptase Region in Chronic Hepatitis B Chinese Patients with Coexistence of HBsAg and Anti-Hbs.

Epidemiological Characteristics of the Carriers with Coexistence of Hbsag and Anti-Hbs Based on A Community Cohort Study

Gene Heterogeneity of Hepatitis B Virus Isolates from Patients with Severe Hepatitis B.

Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.

Mutations of S protein gene in positive HBsAg and anti-HBs patients with chronic hepatitis B virus infection

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen

Coexistence of Hepatitis B Surface Antigen and Anti-Hbs in Chinese Chronic Hepatitis B Virus Patients Relating to Genotype C and Mutations in the S and P Gene Reverse Transcriptase Region

Sequence Analysis of the HBV S Protein in Chinese Patients with Coexisting HBsAg and Anti-Hbs Antibodies.

Characteristics of Amino Acid Substitutions Within the "a" Determinant Region of Hepatitis B Virus in Chronically Infected Patients with Coexisting HBsAg and Anti-Hbs.

Coexistence of Hepatitis B Surface Antigen (hbsag) and Heterologous Subtype-Specific Antibodies to HBsAg among Patients with Chronic Hepatitis B Virus Infection.

The correlations between HBV genotypes and HBsAg mutaion and coexistence of HBsAg/anti-HBs in patients with chronic hepatitis B

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

Specific Mutations in the C-terminus Domain of HBV Surface Antigen Significantly Correlate with Low Level of Serum HBV-DNA in Patients with Chronic HBV Infection.

Hepatitis B Virus Mutations Associated with in Situ Expression of Hepatitis B Core Antigen, Viral Load and Prognosis in Chronic Hepatitis B Patients

Immune-Escape Mutations Are Prevalent among Patients with a Coexistence of HBsAg and Anti-HBs in a Tertiary Liver Center in the United States

Higher Detection Rates of Amino Acid Substitutions in HBV Reverse Transcriptase/surface Protein Overlapping Sequence is Correlated with Lower Serum HBV DNA and HBsAg Levels in HBeAg-positive Chronic Hepatitis B Patients with Subgenotype B2

Detection of Hepatitis B Virus Genome with Mutations Outside the Major Hydrophilic Region in the Surface Antigen Isolated from Patients with Coexisting HBsAg and Anti-HBs

Decreased expression of HBV surface antigen (HBsAg) with sK122R and sV96A co-mutation is associated with an ineffective antibody response in a chronic hepatitis B patient

Relationship Between Genotypes and Mutations in S Gene Sequence of Chronic Hepatitis B Patients with Positive Results for Both HBsAg and HBsAb Tests